People suffering from Type 1 diabetes are set to benefit from an innovative therapy being developed in an EU-funded project that promises to restore the body’s ability to regulate blood sugar via a small bioengineered implant.Powered by WPeMatico
People suffering from Type 1 diabetes are set to benefit from an innovative therapy being developed in an EU-funded project that promises to restore the body’s ability to regulate blood sugar via a small bioengineered implant.